| 000 | 01644 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515155804.0 | ||
| 264 | 0 | _c20090414 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007990802598736 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNair, Kavita V | |
| 245 | 0 | 0 |
_aCategorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cFeb 2009 |
||
| 300 |
_a303-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHealth Expenditures |
| 650 | 0 | 4 |
_aHealth Services _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aInsurance, Health _xclassification |
| 650 | 0 | 4 | _aMedicare |
| 650 | 0 | 4 | _aPrivate Sector |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aTang, Boxiong | |
| 700 | 1 | _aVan Den Bos, Jill | |
| 700 | 1 | _aZhang, Vicki | |
| 700 | 1 | _aSaseen, Joseph J | |
| 700 | 1 | _aNaim, Ahmad | |
| 700 | 1 | _aRahman, Mirza | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 25 _gno. 2 _gp. 303-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007990802598736 _zAvailable from publisher's website |
| 999 |
_c18637768 _d18637768 |
||